Cardio Diagnostics Holdings Inc

Market Cap

$6M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.97-$0.87 (-30.63%)

Jun 22, 2026

52W High $6.5552W Low $1.05

Company Details

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood ...

Leadership

Meeshanthini V. Dogan Ph.D.Founder

Co-Founder, CEO & Director

Elisa Michael Luqman Esq., J.D., M.B.A.

CFO & Principal Accounting Officer

Timur Dogan Ph.D.

Chief Technology Officer

Robert A. Philibert M.D., Ph.D.Founder

Co-Founder, Chief Medical Officer & Director

IPO Date

Jan 14, 2022

Website

cdio.ai

Key Metrics TTM

Revenue

$16.6K

-16.8% YoY

Net Income

-$7M

EPS (Diluted)

Free Cash Flow

-$6M

Revenue / Share

$0.01

Gross Margin

-471.4%

Operating Margin

-40074.6%

Net Margin

-40152.5%

FCF Margin

-36759.7%

P/S

380.5x

P/E

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee